SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
SigRosa
Lv3
3
399 积分
2021-11-16 加入
最近求助
最近应助
互助留言
Targeting immune cell recruitment in atherosclerosis
10小时前
已完结
Can AlphaFold’s breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?
2天前
已完结
Mesenchymal stem cells as therapeutic vehicles for glioma
2天前
已完结
Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening
2天前
已完结
IL-2 targeted to CD8+ T cells promotes robust effector T cell responses and potent antitumor immunity
9天前
已完结
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma
14天前
已完结
Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML
15天前
已完结
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
1个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
1个月前
已完结
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
1个月前
已完结
没有进行任何应助
感谢
8小时前
感谢
1天前
感谢
2天前
感谢
2天前
感谢
9天前
感谢
14天前
感谢
15天前
感谢
1个月前
感谢
1个月前
速度真快
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论